课题基金 / 基金详情

ACTG 185--HIVIG FOR PREVENTION OF MATERNAL/FETAL HIV TRANSMISSION

ACTG 185--HIVIG FOR PREVENTION OF MATERNAL/FETAL HIV TRANSMISSION
ACTG 185--HIVIG 用于预防母婴 HIV 传播
批准号:
6114949
负责人:
MYRON J LEVIN
金额:
$1.99万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

MYRON J LEVIN的其他基金

相似基金

相关文献

中文摘要
翻译
这是一项多中心、随机、对照试验,旨在评价联合应用HIV高免疫球蛋白(HIVIG)的疗效、安全性和耐受性(妊娠期间和出生后12小时内的新生儿)和ZDV(分娩后6周内给予新生儿),与类似给予的IVIG和ZDV相比,减少因医学指征而在怀孕期间接受ZDV的艾滋病毒感染孕妇的艾滋病毒垂直传播。
英文摘要
This is a multicenter, randomized, controlled trial to evaluate the efficacy, safety and tolerance of the combination of HIV hyperimmune globulin (HIVIG) (administered during pregnancy and to the newborn within 12 hours of birth) and ZDV (administered intrapartun and to the newborn for 6 weeks following birth), compared to IVIG and ZDV administered similarly, for the reduction of vertical HIV transmission in HIV-infected pregnant women who are receiving ZDV during pregnancy for medical indications.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PERSISTENCE OF PROTECTION CONFERRED BY SHINGRIX AGAINST HERPES ZOSTER IN OLDER ADULTS
  • 批准号:
    10112818
  • 项目类别:
  • 资助金额:
    $70.5万
  • 财政年份:
    2019
  • 负责人:
    MYRON J LEVIN
  • 依托单位:
PERSISTENCE OF PROTECTION CONFERRED BY SHINGRIX AGAINST HERPES ZOSTER IN OLDER ADULTS
  • 批准号:
    9886187
  • 项目类别:
  • 资助金额:
    $71.55万
  • 财政年份:
    2019
  • 负责人:
    MYRON J LEVIN
  • 依托单位:
PERSISTENCE OF PROTECTION CONFERRED BY SHINGRIX AGAINST HERPES ZOSTER IN OLDER ADULTS
  • 批准号:
    10580099
  • 项目类别:
  • 资助金额:
    $68.53万
  • 财政年份:
    2019
  • 负责人:
    MYRON J LEVIN
  • 依托单位:
PERSISTENCE OF PROTECTION CONFERRED BY SHINGRIX AGAINST HERPES ZOSTER IN OLDER ADULTS
  • 批准号:
    10363620
  • 项目类别:
  • 资助金额:
    $69.98万
  • 财政年份:
    2019
  • 负责人:
    MYRON J LEVIN
  • 依托单位:
海外基金